|
|
 e-Newsletter
|
|
A researcher from the University of Illinois College of Medicine at Peoria is presenting his findings at an Alzheimer’s conference this week. Doctor Ken Fukuchi says he tested an antibody in mice that targets plaque on brain cells believed to cause the brain disease. He says half of the mice showed reduced plaque levels and better cognitive functions up to a year after receiving the antibody:
“If we place these animals in a maze test, they improve their performance in the maze test,” Fukuchi says.
“So we’re hoping that also this will be true in human patients.”
Fukuchi says the test results could lead to eventual clinical trials. He’s one of thousands of researchers from across the world presenting their findings at the Alzheimer’s conference in Vancouver. Researchers are also meeting to discuss new therapies that might slow the spread of Alzheimer’s.
|
|||
